Skip to content

The effect of scalp nerve block combined with inhaled peppermint aromatherapy on postoperative pain in patients undergoing supratentorial tumor resection

The effect of scalp nerve block combined with inhaled peppermint aromatherapy on postoperative pain in patients undergoing supratentorial tumor resection

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093276
Enrollment
Unknown
Registered
2024-12-02
Start date
2024-12-02
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

supratentorial tumors

Interventions

Control group:Inhale cotton pads dipped in physiological saline for 10 minutes on the day before surgery, before induction, and immediately after extubation
Scalp nerve block group:After induction is completed, scalp nerve block is performed under ultrasound guidance
EPO group:Inhale cotton pads dipped in peppermint essential oil for 10 minutes on the day before surgery, before induction, and immediately after extubation
SNB+EPO group:After induction is completed, scalp nerve block is performed under ultrasound guidance.Inhale cotton pads dipped in peppermint essential oil for 10 minutes on the day before surgery, bef

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Planned elective supratentorial tumor resection surgery; 2. ASA: Level I-III; 3. Age range of 18 to 65 years old; 4. Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Taboos for scalp nerve block; 2. Abnormal coagulation function, puncture site infection, local anesthetic allergy, etc; 3. Long term use of painkillers for treatment; 4. History of neurological and psychiatric disorders, and long-term use of sedatives; 5. Allergic or olfactory abnormalities to peppermint essential oil; 6. Patients with cardiomyopathy or persistent arrhythmia or other rhythm abnormalities; 7. Patients with severe liver and kidney dysfunction; 8. Patients who undergo any radiotherapy or chemotherapy before surgery.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale(VAS);

Secondary

MeasureTime frame
Number of occurrences of nausea and vomiting;State anxiety inventory(SAI);Recovery Quality QoR-15 Score;

Countries

China

Contacts

Public ContactMaoyin Zhang

The Affiliated Hospital of Xuzhou Medical University

540072028@qq.com+86 159 5220 5566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026